Myocardial bridging: what have we learned in the past and will new diagnostic modalities provide new insights?

A V G Bruschke1, C E Veltman, M A de Graaf

  • 1Department of Cardiology -C5, Leiden University Medical Center, P.O. Box 9600, 2300 RC, Leiden, the Netherlands, abruschke@freeler.nl.

Insights

Myocardial bridging diagnosis has evolved with computed tomography coronary angiography (CTCA) offering higher sensitivity than coronary arteriography (CAG). Further research combining CTCA and CAG is needed to optimize patient management.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Diagnostic Techniques

Background:

  • The clinical significance of myocardial bridging remains debated since the advent of coronary arteriography (CAG).
  • Computed tomography coronary angiography (CTCA) has emerged as a more sensitive tool for visualizing myocardial bridging.
  • A growing number of patients are diagnosed with myocardial bridging, necessitating optimized management strategies.

Purpose of the Study:

  • To critically review existing studies on myocardial bridging.
  • To define unresolved questions regarding myocardial bridging pathophysiology and management.
  • To guide the optimization of patient care for myocardial bridging.

Main Methods:

  • Review of previous studies on myocardial bridging.
  • Comparison of diagnostic sensitivities between CAG and CTCA.
  • Discussion of combining CTCA with invasive techniques like CAG.

Main Results:

  • CTCA demonstrates higher sensitivity in detecting myocardial bridging compared to CAG.
  • Combining CTCA with invasive methods holds potential for improved understanding and answers.
  • Current literature provides a basis for identifying knowledge gaps.

Conclusions:

  • Myocardial bridging diagnosis and understanding have advanced with CTCA.
  • Further research integrating CTCA and CAG is crucial for resolving clinical questions.
  • Optimizing the management of myocardial bridging patients requires addressing remaining uncertainties.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...